Published in
American Medical Association, JAMA Oncology, 3(5), p. 343, 2019
DOI: 10.1001/jamaoncol.2018.5080
Links
Tools
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
Journal article published in 2019 by
Chiara Cremolini 
,
Daniele Rossini,
Emanuela Dell’Aquila,
Sara Lonardi,
Elena Conca,
Marzia Del Re ,
Adele Busico ,
Filippo Pietrantonio,
Romano Danesi,
Giuseppe Aprile,
Emiliano Tamburini ,
Carlo Barone,
Gianluca Masi,
Francesco Pantano ,
Francesca Pucci
and other authors.
,
Daniele Rossini,
Emanuela Dell’Aquila,
Sara Lonardi,
Elena Conca,
Marzia Del Re ,
Adele Busico ,
Filippo Pietrantonio,
Romano Danesi,
Giuseppe Aprile,
Emiliano Tamburini ,
Carlo Barone,
Gianluca Masi,
Francesco Pantano ,
Francesca Pucci
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 